CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?

CVRx scored a strong price increase driven by the optimism surrounding the company's recent presentation at William Blair 44rd Annual Growth Stock Conference held on Jun 5, 2024. The company drew attention to the massive $2.2 billion U.S. annual net addressable market for Barostim device and plans to drive the therapy to a standard of care. In addition, CVRx reaffirmed its financial outlook for the second quarter and full year 2024, issued during the first quarter earnings call. For CVRx, the consensus EPS ...